Seoul, South Korea

Hye-Ja Lee

This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignee: Medexgen Co., Ltd.. Active years: 2007-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hye-Ja Lee. Retrieved from https://idiyas.com/inventor/hye-ja-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 66.7


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 45(Granted Patents)


Company Filing History:


Years Active: 2007-2013

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Hye-Ja Lee: Innovator in Immunoadhesion Molecules

Introduction

Hye-Ja Lee is a prominent inventor based in Seoul, South Korea. She has made significant contributions to the field of biotechnology, particularly in the development of concatameric immunoadhesion molecules. With a total of 3 patents to her name, her work has the potential to impact pharmaceutical and diagnostic applications.

Latest Patents

Hye-Ja Lee's latest patents include innovative technologies related to polynucleotides encoding concatameric immunoadhesion molecules. These patents disclose concatameric proteins that consist of two soluble domains. The C-terminus of a soluble domain of a biologically active protein is linked to the N-terminus of either an identical or distinct soluble domain of another biologically active protein. Furthermore, her inventions describe dimeric proteins formed through intermolecular disulfide bonds at the hinge region of two monomeric proteins. These proteins are linked by a concatamer of two identical soluble extracellular regions, which are involved in immune responses to an Fc fragment of an immunoglobulin molecule. The patents also cover glycosylated proteins, DNA constructs encoding the monomeric proteins, and recombinant expression plasmids. Additionally, they detail methods for preparing the dimeric proteins by culturing host cells, as well as pharmaceutical or diagnostic compositions that include the dimeric protein or its glycosylated form.

Career Highlights

Hye-Ja Lee is currently associated with Medexgen Co., Ltd., where she continues to advance her research and development efforts. Her work is characterized by a strong focus on innovative solutions in the field of immunology and biotechnology.

Collaborations

Hye-Ja Lee collaborates with notable colleagues, including Yong-Hoon Chung and Ji-Woong Han. These partnerships enhance her research capabilities and contribute to the advancement of her projects.

Conclusion

Hye-Ja Lee is a trailblazer in the field of immunoadhesion molecules, with a promising portfolio of patents that reflect her innovative spirit. Her contributions are poised to make a significant impact in the biotechnology sector.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…